Uber, Lyft launch U.S. vaccine rides program in White House partnership

Reuters2021-05-24

May 24 (Reuters) - Uber Technologies Inc and rival Lyft Inc on Monday launched COVID-19 vaccine ride programs in partnership with the White House, offering Americans free rides or discounts for their trips to and from a vaccination site.

Customers who have booked a vaccine appointment can request a ride through the Uber app and either incur no charges if the trip costs less than $25, or receive a $25 discount for their journey, the company said.

With two of the three COVID-19 vaccines available in the United States requiring two separate shots, Uber would pay a maximum of $100 per passenger under the program. A company spokesman said Uber does not have an estimate for the number of vaccine rides it expects to provide.

Lyft said it would provide a $15 discount for one round trip, for a total discount of $30 per passenger.

Drivers will receive the full payment for the trip, the companies said.

U.S. President Joe Biden two weeks ago announced the partnership with Uber and its rival Lyft Inc in an effort to boost COVID-19 vaccination rates at a time when U.S. demand for vaccines has declined.

Many states are offering incentives, from free food and drinks to a chance at winning a lottery, in order to get more Americans to roll up their sleeves for a COVID-19 shot.

Biden has set a target of getting 70% of U.S. adults inoculated by July 4 so the country can be safely reopened for celebrations and small Independence Day holiday gatherings. As of Sunday, 49% of Americans have received at least one vaccine dose, according to the U.S. Centers for Disease Control and Prevention.

For Uber and Lyft, the vaccine efforts also come as the companies seek to have drivers and riders return to the road and recover revenue lost during the pandemic.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Leave a comment
64